MLN Matters Article (Revised) MM12403: National Coverage Determination (NCD) 270.3 Blood-Derived Products for Chronic, Non-Healing Wounds
This revised Article comprises Subregulatory Guidance for national coverage of autologous Platelet-Rich Plasma (PRP) for the treatment of chronic non-healing diabetic wounds under specific conditions. MLN Matters (MM) Articles are based on information contained within Change Requests (CRs). In this case, this article is based on content within CR12403 that is posted on the CMS website at https://www.cms.gov/files/document/r11214cp.pdf and https://www.cms.gov/files/document/r11214NCD.pdf.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: January 24, 2022
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.